Approvals/CIMA-AEMPS/BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Gilead Sciences Ireland Unlimited Company🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6be71d8ad889d8ac
Drug Cima Aemps Name: BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 181289001IP
Holder Company Name: Gilead Sciences Ireland Unlimited Company
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company
Authorization Date: 2022-05-17
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 200 mg/25 mg/50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Gilead Sciences Ireland Unlimited Company
Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company

BICTEGRAVIR SODIO

52,45 mg

EMTRICITABINA

200 mg

TENOFOVIR ALAFENAMIDA FUMARATO

28,04 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 17, 2022

Approval ID

6be71d8ad889d8ac

Type

Standard